Skip to main content
Top
Published in: Acta Diabetologica 7/2018

01-07-2018 | Original Article

Characterization of circulating leukocytes and correlation of leukocyte subsets with metabolic parameters 1 and 5 years after diabetes diagnosis

Authors: Maria Apostolopoulou, Barbara Menart-Houtermans, Ruth Ruetter, Bettina Nowotny, Ulrich Gehrmann, Daniel Markgraf, Julia Szendroedi, Nanette C. Schloot, Michael Roden

Published in: Acta Diabetologica | Issue 7/2018

Login to get access

Abstract

Aims

Infiltration of pancreatic islets with different leukocyte subtypes likely contributes to deterioration of glycemia in diabetes mellitus. Different subsets of leukocytes have been previously associated with type 1 or type 2 diabetes. This study aimed at examining these subsets at different stages of diabetes progression and possible relationships with metabolic parameters.

Methods

A total of 206 patients, 76 with type 1 and 130 with type 2 diabetes, were studied within the first year of diabetes diagnosis. In addition, 31 patients with type 1 and 73 with type 2 diabetes were examined at 5 years after diagnosis. Whole body insulin sensitivity was assessed by hyperinsulinemic–euglycemic clamps; insulin secretion by glucagon stimulation tests and white blood cells were analyzed by flow cytometry.

Results

The percentage of peripheral CD8+ cells was 15% lower in patients with type 1 diabetes at 5 years than in patients at diabetes onset and correlated positively with fasting glycemia, total cholesterol and high-sensitive C-reactive protein (hsCRP) (all r > 0.37, p < 0.05), but not with insulin secretion. Patients with type 2 diabetes had 7% higher percentages of CD4+ cells after 5 years than those at diagnosis. CD4+ cells correlated with hsCRP (r = 0.36, p < 0.05), whereas CD8+ cytotoxic T-cells did not correlate with any metabolic parameter.

Conclusion

CD8+ T-cells associate with worse glycemia, lipidemia and inflammation after 5 years of type 1 diabetes, whereas CD4+ T-cells associate with increased inflammation after 5 years upon onset of type 2 diabetes.
Appendix
Available only for authorised users
Literature
3.
go back to reference Kaul K, Apostolopoulou M, Roden M (2015) Insulin resistance in type 1 diabetes mellitus. Metab Clin Exp 64:1629–1639CrossRefPubMed Kaul K, Apostolopoulou M, Roden M (2015) Insulin resistance in type 1 diabetes mellitus. Metab Clin Exp 64:1629–1639CrossRefPubMed
5.
go back to reference Rodriguez-Calvo T, Ekwall O, Amirian N, Zapardiel-Gonzalo J, von Herrath MG (2014) Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63:3880–3890CrossRefPubMedPubMedCentral Rodriguez-Calvo T, Ekwall O, Amirian N, Zapardiel-Gonzalo J, von Herrath MG (2014) Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63:3880–3890CrossRefPubMedPubMedCentral
6.
go back to reference Lundberg M, Seiron P, Ingvast S, Korsgren O, Skog O (2017) Insulitis in human diabetes: a histological evaluation of donor pancreases. Diabetologia 60:346–353CrossRefPubMed Lundberg M, Seiron P, Ingvast S, Korsgren O, Skog O (2017) Insulitis in human diabetes: a histological evaluation of donor pancreases. Diabetologia 60:346–353CrossRefPubMed
7.
go back to reference Williams MD, Nadler JL (2007) Inflammatory mechanisms of diabetic complications. Curr Diabetes Rep 7:242–248CrossRef Williams MD, Nadler JL (2007) Inflammatory mechanisms of diabetic complications. Curr Diabetes Rep 7:242–248CrossRef
8.
go back to reference Menart-Houtermans B, Rutter R, Nowotny B et al (2014) Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS). Diabetes Care 37:2326–2333CrossRefPubMed Menart-Houtermans B, Rutter R, Nowotny B et al (2014) Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS). Diabetes Care 37:2326–2333CrossRefPubMed
9.
go back to reference Sarikonda G, Pettus J, Phatak S et al (2014) CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. J Autoimmun 50:77–82CrossRefPubMed Sarikonda G, Pettus J, Phatak S et al (2014) CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. J Autoimmun 50:77–82CrossRefPubMed
10.
go back to reference Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107CrossRefPubMed Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107CrossRefPubMed
12.
13.
go back to reference Brooks-Worrell BM, Boyko EJ, Palmer JP (2014) Impact of islet autoimmunity on the progressive beta-cell functional decline in type 2 diabetes. Diabetes Care 37:3286–3293CrossRefPubMedPubMedCentral Brooks-Worrell BM, Boyko EJ, Palmer JP (2014) Impact of islet autoimmunity on the progressive beta-cell functional decline in type 2 diabetes. Diabetes Care 37:3286–3293CrossRefPubMedPubMedCentral
14.
go back to reference Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA (2008) Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31(Suppl 2):S161–S164CrossRefPubMed Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA (2008) Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31(Suppl 2):S161–S164CrossRefPubMed
16.
go back to reference Greenbaum CJ, Mandrup-Poulsen T, McGee PF et al (2008) Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 31:1966–1971CrossRefPubMedPubMedCentral Greenbaum CJ, Mandrup-Poulsen T, McGee PF et al (2008) Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 31:1966–1971CrossRefPubMedPubMedCentral
17.
go back to reference Chung FM, Tsai JC, Chang DM, Shin SJ, Lee YJ (2005) Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis. Diabetes Care 28:1710–1717CrossRefPubMed Chung FM, Tsai JC, Chang DM, Shin SJ, Lee YJ (2005) Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis. Diabetes Care 28:1710–1717CrossRefPubMed
18.
go back to reference Pertynska-Marczewska M, Kiriakidis S, Wait R, Beech J, Feldmann M, Paleolog EM (2004) Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages. Cytokine 28:35–47CrossRefPubMed Pertynska-Marczewska M, Kiriakidis S, Wait R, Beech J, Feldmann M, Paleolog EM (2004) Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages. Cytokine 28:35–47CrossRefPubMed
19.
go back to reference Sell H, Habich C, Eckel J (2012) Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol 8:709–716CrossRefPubMed Sell H, Habich C, Eckel J (2012) Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol 8:709–716CrossRefPubMed
20.
go back to reference McLaughlin T, Liu LF, Lamendola C et al (2014) T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol 34:2637–2643CrossRefPubMedPubMedCentral McLaughlin T, Liu LF, Lamendola C et al (2014) T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol 34:2637–2643CrossRefPubMedPubMedCentral
21.
22.
go back to reference Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8:301–309CrossRefPubMedPubMedCentral Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8:301–309CrossRefPubMedPubMedCentral
23.
go back to reference Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–107CrossRefPubMed Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–107CrossRefPubMed
24.
go back to reference Coppieters KT, Dotta F, Amirian N et al (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209:51–60CrossRefPubMedPubMedCentral Coppieters KT, Dotta F, Amirian N et al (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209:51–60CrossRefPubMedPubMedCentral
25.
go back to reference Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun Héè L (2014) Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol 5:470CrossRefPubMedPubMedCentral Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun Héè L (2014) Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol 5:470CrossRefPubMedPubMedCentral
26.
go back to reference Zeyda M, Farmer D, Todoric J et al (2007) Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (2005) 31:1420–1428CrossRef Zeyda M, Farmer D, Todoric J et al (2007) Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (2005) 31:1420–1428CrossRef
27.
go back to reference Dworacka M, Wesolowska A, Wysocka E, Winiarska H, Iskakova S, Dworacki G (2014) Circulating CD3+56+ cell subset in pre-diabetes. Exp Clin Endocrinol Diabetes Off J Germ Soc Endocrinol Germ Diabetes Assoc 122:65–70 Dworacka M, Wesolowska A, Wysocka E, Winiarska H, Iskakova S, Dworacki G (2014) Circulating CD3+56+ cell subset in pre-diabetes. Exp Clin Endocrinol Diabetes Off J Germ Soc Endocrinol Germ Diabetes Assoc 122:65–70
Metadata
Title
Characterization of circulating leukocytes and correlation of leukocyte subsets with metabolic parameters 1 and 5 years after diabetes diagnosis
Authors
Maria Apostolopoulou
Barbara Menart-Houtermans
Ruth Ruetter
Bettina Nowotny
Ulrich Gehrmann
Daniel Markgraf
Julia Szendroedi
Nanette C. Schloot
Michael Roden
Publication date
01-07-2018
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 7/2018
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1143-x

Other articles of this Issue 7/2018

Acta Diabetologica 7/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.